fluocinonide has been researched along with Keratoderma Blennorrhagicum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Linstrum, J; Skelton, H; Smith, K | 1 |
| Rees, RB | 1 |
1 review(s) available for fluocinonide and Keratoderma Blennorrhagicum
| Article | Year |
|---|---|
Current dermatologic therapy.
Topics: Acne Vulgaris; Administration, Topical; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Betamethasone; Cryosurgery; Dermatomycoses; Flucytosine; Fluocinonide; Fluorouracil; Herpes Simplex; Humans; Keratosis; Levamisole; Propylene Glycols; Psoriasis; Pyoderma; Skin Diseases; Skin Neoplasms; Vitamin A; Warts | 1976 |
1 other study(ies) available for fluocinonide and Keratoderma Blennorrhagicum
| Article | Year |
|---|---|
Host-vs.-altered-host eruptions in patients on liposomal doxorubicin.
Topics: Acanthosis Nigricans; Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma; Cytotoxicity, Immunologic; Doxorubicin; Drug Eruptions; Erythema; Female; Fluocinonide; Glucocorticoids; Humans; Keratosis; Liposomes; Middle Aged; Ovarian Neoplasms; Treatment Outcome | 2002 |